Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Amortization of Deferred Charges (2017 - 2023)

Neurocrine Biosciences' Amortization of Deferred Charges history spans 7 years, with the latest figure at $100000.0 for Q4 2023.

  • For Q4 2023, Amortization of Deferred Charges fell 50.0% year-over-year to $100000.0; the TTM value through Dec 2023 reached $700000.0, down 41.67%, while the annual FY2023 figure was $700000.0, 41.67% down from the prior year.
  • Amortization of Deferred Charges reached $100000.0 in Q4 2023 per NBIX's latest filing, down from $200000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $400000.0 in Q2 2019 to a low of $100000.0 in Q4 2023.
  • Average Amortization of Deferred Charges over 5 years is $290000.0, with a median of $300000.0 recorded in 2019.
  • Peak YoY movement for Amortization of Deferred Charges: surged 33.33% in 2022, then tumbled 50.0% in 2023.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020, then fell by 25.0% to $300000.0 in 2021, then tumbled by 33.33% to $200000.0 in 2022, then crashed by 50.0% to $100000.0 in 2023.
  • Per Business Quant, the three most recent readings for NBIX's Amortization of Deferred Charges are $100000.0 (Q4 2023), $200000.0 (Q3 2023), and $200000.0 (Q2 2023).